A vaccine trial into the safety and efficacy of the Oxford/AstraZeneca vaccine in children has been paused while the UK medicines regulator investigates a possible link to rare blood clots in adults who had the jab.
A spokesperson from Oxford university said in a statement: “Whilst there are no safety concerns in the paediatric clinical trial, we await additional information from the MHRA on its review of rare cases of thrombosis/thrombocytopaenia that have been reported in adults, before giving any further vaccinations in the trial. Parents and children should continue to attend all scheduled visits and can contact the trial sites if they have any questions.”
